DOCSLIB.ORG

Small Vessel Diseases

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Small Vessel Diseases The University of Notre Dame Australia ResearchOnline@ND Medical Papers and Journal Articles School of Medicine 2020 Systemic vasculitides. Part 2: Small vessel diseases Sean M. Conte Peter R. Vale Follow this and additional works at: https://researchonline.nd.edu.au/med_article Part of the Medicine and Health Sciences Commons This article was originally published as: Conte, S. M., & Vale, P. R. (2020). Systemic vasculitides. Part 2: Small vessel diseases. Medicine Today, 21 (5), 21-27. Original article available here: https://medicinetoday.com.au/2020/may/feature-article/systemic-vasculitides-part-2-small-vessel-diseases This article is posted on ResearchOnline@ND at . For more information, please contact [email protected]. This article originally published: - Conte, S. and Vale, P.R. (2020) Systemic vasculitides. Part 2: Small vessel diseases. Medicine Today, 21(5): 21-27. Permission granted by Medicine Today for use on ResearchOnline@ND. © Medicine Today 2020 (http://www.medicinetoday.com.au). PEER REVIEWED FEATURE Systemic vasculitides Part 2: Small vessel diseases SEAN M. CONTE BA, MB BS; PETER R. VALE MB BS, FRACP, FCSANZ, FACC, FACP Small vessel vasculitides often manifest as neurological, renal, pulmonary and dermatological KEY POINTS symptoms. Clinical features of systemic vasculitides • The two main categories of small vessel vasculitis are are often nonspecific; therefore, it is important that antineutrophil cytoplasmic antibody-associated and GPs be aware of the range of symptoms that can immune complex-associated disease, best diagnosed help in the differential diagnosis, treatment and with renal and/or pulmonary biopsy. management of this diverse group of conditions. • Severe renal failure and pulmonary haemorrhage are high-risk features that require urgent management. • Eosinophilic granulomatosis with polyangiitis can be art one of this two-part series on systemic vasculitides associated with severe cardiac disease including heart covered the large, medium and variable vessel vascu- failure, conduction abnormalities and pericarditis. litides. We saw that most primary vasculitides are These complications account for half of the mortality typified by nonspecific systemic manifestations such as associated with this disease. Pfever, weight loss and lethargy but that classic presentations often • Hypocomplementaemic urticarial vasculitis and aid our diagnostic efforts. We also stressed the importance of cryoglobulinaemic vasculitis are commonly associated with underlying systemic conditions including identifying high-mortality and high-morbidity situations such inflammatory rheumatological disease, chronic viral as visual impairment in giant cell arteritis (GCA) and coronary hepatitis and haematological malignancies. These artery aneurysms in Kawasaki disease. should be screened for at the time of diagnosis. Part two will discuss small vessel diseases, a diverse group • Leukocytoclastic vasculitis is the most common of diseases often with neurological, renal, pulmonary and vasculitis encountered in clinical practice, only involves dermatological manifestations, which are summarised in Table 1. the skin and is most commonly associated with We will conclude with a summary outlining a general approach medication use. • Patients receiving long-term corticosteroid or immuno- suppressive therapy require dedicated screening for MedicineToday 2020; 21(5): 21-27 chronic iatrogenic complications such as diabetes mellitus, osteoporosis, hypertension, obesity, Dr Conte is a Medical Registrar and RACP Trainee at St Vincent’s Hospital, opportunistic infections and secondary malignancies. Sydney; and Clinical Associate Lecturer at UNSW, Sydney and the University of Notre Dame Australia, Sydney. Professor Vale is a Professor of Medicine at The University of Notre Dame Australia, Sydney; and a Vascular Physician and Cardiologist at Mater © HEALTH CARE/STOCK.ADOBE.COM Hospital, Sydney, NSW. MedicineToday ❙ MAY 2020, VOLUME 21, NUMBER 5 21 Downloaded for personal use only. No other uses permitted without permission. © MedicineToday 2020. SYSTEMIC vasculITIDES PART 2 continued TABLE 1. SUMMARY OF CLINICAL FEATURES AND ASSESSMENT OF SMALL VESICLE DISEASE VASCULITIDES Disease entity Clinical patient features Investigations and diagnosis Management options Granulomatosis with • Sinusitis • Cytoplasmic antineutrophil • Induction: corticosteroids + polyangiitis (GPA) / • Haemoptysis cytoplasmic antibodies: protease cyclophosphamide or rituximab microscopic • Haematuria 3 (granulomatosis with • Maintenance: azathioprine, polyangiitis (MPA) polyangiitis), myeloperoxidase methotrexate, rituximab (GPA) (MPA) Eosinophilic • Asthma, atopy • p-ANCA • Induction: corticosteroids +/− granulomatosis with • Mononeuritis multiplex • Eosinophilia cyclophosphamide polyangiitis • Cardiac conduction • Chest imaging (patchy opacities) • Maintenance: azathioprine, abnormalities • Surgical lung biopsy methotrexate, leflunomide • Anti-interleukin-5 monoclonal antibody Anti-glomerular • Haemoptysis • p-ANCA • Critical/Emergent: intubation, basement membrane • Haematuria • Myeloperoxidase dialysis disease • Acute renal failure • Antibodies against type IV • Initial: plasmapheresis + collagen on ELISA, western blot, corticosteroid + and immunofluorescence of renal cyclophosphamide or pulmonary biopsy • Alternate: rituximab or mycophenolate • Maintenance: low-dose prednisolone +/− second agent IgA-related vasculitis • Asian populations • Renal function • Uncomplicated: NSAIDs, rest, • Palpable purpura on lower • Urine sediment hydration limbs and buttocks • Urine protein • Proteinuria: ACE inhibitor or ARB • Migratory oligoarthralgia • Immunofluorescence of biopsy • Prolonged: low-dose prednisolone • Abdominal pain specimen (IgA) • Severe or marked renal • IgA nephropathy dysfunction: mycophenolate +/− cyclophosphamide Hypocomplementaemic • Constitutional symptoms • Low C3 and C4 • Mild: NSAIDs and antihistamines urticarial vasculitis • Chronic obstructive • Leukocytoclastic vasculitis on • Moderate: prednisolone + pulmonary disease biopsy colchicine, dapsone, • Mild renal dysfunction • Renal function and urinalysis hydroxychloroquine • Migratory polyarthritis • Hepatitis serology • Severe: mycophenolate • Associations: SLE, Sjögren’s • ANCA, antinuclear antibody, disease, drugs, HCV and extractable nuclear antigens, etc. HBV, complement deficiency, • Serum protein electrophoresis haematological malignancies and immunofixation Cryoglobulinaemic • Cutaneous manifestations • Screening for connective tissue • Mild: NSAIDs, rest hydration vasculitis • Arthralgias (hands, knees, diseases (SLE, Sjögren’s) • Proteinuria: ACE inhibitor or ARB ankles) • Screening for haematological • Moderate: low-dose prednisolone • Peripheral neuropathy malignancy (multiple myeloma, • Severe/prolonged: • Glomerulonephritis Waldenström’s) cyclophosphamide +/− • Evaluation of renal function and mycophenolate proteinuria • Renal biopsy Leukocytoclastic • Temporal relationship to new • Absence of evidence of major • Supportive care vasculitis or changed medication visceral involvement • Cessation of offending • Palpable purpura • Exclusion of systemic vasculitis medication • Maculopapular rash or infection • Perivascular neutrophils • Fibrinoid necrosis Abbreviations: ARB = angiotensin-receptor blocker; c-ANCA = cytoplasmic antineutrophil cytoplasmic antibodies; ELISA = enzyme-linked immunosorbent assay; HBV = hepatitis B virus; HCV = hepatitis C virus; IgA = immunoglobin A; p-ANCA = peripheral antineutrophil cytoplasmic antibodies; SLE = systemic lupus erythematosus. 22 MedicineToday ❙ MAY 2020, VOLUME 21, NUMBER 5 Downloaded for personal use only. No other uses permitted without permission. © MedicineToday 2020. to investigating and managing systemic 2. in those with pulmonary vasculitides. haemorrhage 3. in the presence of concomitant Classification and clinical anti-glomerular basement features membrane antibodies.3 Antineutrophil cytoplasmic Maintenance therapy is started once antibody-associated vasculitis corticosteroids are tapered, usually after Granulomatosis with polyangiitis and three to six months, and preferred agents microscopic polyangiitis are azathioprine or methotrexate. Rituxi- Granulomatosis with polyangiitis (GPA), mab is an alternative agent for maintenance formerly known as Wegener’s disease, therapy but is not recommended for MPO- Figure 1. CT of the chest in a patient with and microscopic polyangiitis (MPA) most ANCA positive disease.4 granulomatosis with polyangiitis. commonly occur in patients over the age Case courtesy of Radswiki, Radiopaedia.org, rID: 12079. of 65 years and more often in Caucasian Eosinophilic granulomatosis with populations, affecting men and women polyangiitis pulmonary biopsy. Surgical lung biopsy equally. GPA affects the respiratory and Eosinophilic granulomatosis with poly- revealing extravascular granulomas with glomerular epithelia producing haemop- angiitis (EGPA), formerly known as eosinophilic pneumonia is the gold stand- tysis and haematuria, respectively. Ear, Churg-Strauss syndrome, is a multi system ard diagnostic test for EGPA and is superior nose and throat (ENT) manifestations vasculitis of the small and medium-sized in demonstrating typical histopathology such as sinusitis, otitis media, ulcers, vessel with gradual onset in the second or to a transbronchial approach.6 Spirometry polychondritis and subglottic stenosis third decade of life. EGPA is typified by and pulmonary function testing typically are also classically
Load more

Recommended publications
  • Apixaban-Induced Cutaneous Hypersensitivity: a Case Series with Evidence of Cross-Reactivity
    Volume 26 Number 10| October 2020| Dermatology Online Journal || Letter 26(10):20 Apixaban-induced cutaneous hypersensitivity: a case series with evidence of cross-reactivity Nasro A Isaq1 BS, Whitney M Vinson2 MD, Sahand Rahnama-Moghadam2 MD MS Affiliations: 1Indiana University School of Medicine, Indianapolis, Indiana, USA, 2Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana, USA Corresponding Author: Sahand Rahnama-Moghadan MD MS, Department of Dermatology, Indiana University School of Medicine, 545 Barnhill Drive, Emerson Hall 139, Indianapolis, IN 46202, Tel: 317-944-7744, Email: [email protected] Keywords: novel oral anticoagulants (NOACs), apixaban, 2 weeks she developed low-grade fevers, chills, rivaroxaban, drug induced rash, apixaban hypersensitivity nausea, shortness of breath, headaches, and cough. reaction, rivaroxaban cross reactivity, novel oral She was admitted to the hospital where computed anticoagulant induced hypersensitivity reaction, apixaban tomography of the chest demonstrated ground glass induced rash opacities located peripherally within her lungs. Laboratory results showed a decrease in hemoglobin, elevated dsDNA, positive rheumatoid To the Editor: factor, and elevated beta-2 glycoprotein concerning Atrial fibrillation is the most common cardiac arrhythmia affecting more than 2.7 million patients for drug-induced lupus. Her apixaban was held owing to concern for hemorrhage. A in the US [1]. As the population ages, it is predicted bronchoalveolar lavage was performed revealing to affect more than 6-12 million people by 2050 [1]. eosinophilic predominance, suggestive of Patients with atrial fibrillation are at increased risk for eosinophilic pneumonia secondary to a connective thromboembolic events and require anticoagulation therapy to prevent thrombus formation and stroke. tissue disease versus drug reaction.
    [Show full text]
  • Goodpasture Syndrome
    orphananesthesia Anaesthesia recommendations for Goodpasture syndrome Disease name: Goodpasture syndrome ICD 10: M31.0 Synonyms: Goodpasture’s syndrome (GS), anti-glomerular basement membrane disease, crescentic glomerulonephritis type 1, GPS Disease summary: Goodpasture syndrome is a rare and organ-specific autoimmune disease (Gell and Coombs classification type II). It is mediated by anti-glomerular basement membrane (anti-GBM) antibodies [7]. The disease was first described by Dr. Ernest Goodpasture in 1919 [6], whereby the glomerular basement membrane was first identified as antigen in 1950s. More than one decade later, researchers succeeded in defining the association between antibodies taken from diseased kidneys and nephritis [7]. The disorder is characterised by autoantibodies targeting at the NC1-domain of the α3 chain of type IV collagen in the glomerular and alveolar basement membrane with activation of the complement cascade among other things [7,17]. The exclusive location of this α3 subunit in basement membranes only in lung and kidney is responsible for the unique affection of these two organs in GPS [7]. Nevertheless, the aetiology and the triggering stimuli for anti-GBM production remain unknown. Due to the fact that patients with specific human leukocyte antigen (HLA) types are more susceptible, a genetic predisposition HLA-associated seems possible [4,7]. However, because this strongly associated allele is frequently present, there seem to be additional behavioural or environmental factors influencing immune response and disease expression. The latter may include respiratory infections (e.g., influenza A2), exposition to hydrocarbon fumes, organic solvents, metallic dust, tobacco smoke, certain drugs (i.e., rifampicin, allopurinol, cocaine), physical damage to basement membrane (e.g., lithotripsy or membranous glomerulonephritis) as well as lymphocyte-depletion therapy (such as alemtuzumab), but unequivocal evidence is lacking [4,7,9,17].
    [Show full text]
  • Goodpasture's Syndrome: an Analysis of 29 Cases
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Kidney International, Vol. 13 (1978), pp. 492—504 Goodpasture's syndrome: An analysis of 29 cases CLINTON A. TEAGUE, PETER B. DOAK, IAN J. SIMPSON, STEPHEN P. RAINER, and PETER B. HERDSON The Departments of Pathology and Medicine, University of Auckland School of Medicine, Auckland, New Zealand Goodpasture's syndrome: An analysis of 29 cases. The patho- ation between lung hemorrhage and glomeruloneph- logic features of 29 cases of Goodpasture's syndrome occurring during a 13-yr period in Auckland have been reviewed and corre- ntis classically affecting young men. They referred to lated with clinical findings. There were 20 males and nine females such a patient reported about 40 years previously by in the series; two of the males and three of the females were Goodpasture [2]. During the past two decades, a Maoris. Age at the time of onset of symptoms ranged from 17 to 75 great deal has been learned about the immunological yr, with about 76% of the patients being from 17 to 27 yr of age. Sixteen (55%) of the patients died from less than a week up to aspects of several forms of glomerulonephritis, in- about two years following the onset of symptoms, and the remain- cluding the anti-glomerular basement membrane ing 13 are alive from 30 weeks to 14 yr after initial presentation. (anti-GBM) type of disease with cross-reactivity be- Underlying renal disease varied from mild focal glomerulitis to end-stage glomerulonephritis by light microscopy, but characteris- tween lung and kidney which is a feature of Good- tic glomerular changes were seen in all specimens examined by pasture's syndrome [3].
    [Show full text]
  • ANCA--Associated Small-Vessel Vasculitis
    ANCA–Associated Small-Vessel Vasculitis ISHAK A. MANSI, M.D., PH.D., ADRIANA OPRAN, M.D., and FRED ROSNER, M.D. Mount Sinai Services at Queens Hospital Center, Jamaica, New York and the Mount Sinai School of Medicine, New York, New York Antineutrophil cytoplasmic antibodies (ANCA)–associated vasculitis is the most common primary sys- temic small-vessel vasculitis to occur in adults. Although the etiology is not always known, the inci- dence of vasculitis is increasing, and the diagnosis and management of patients may be challenging because of its relative infrequency, changing nomenclature, and variability of clinical expression. Advances in clinical management have been achieved during the past few years, and many ongoing studies are pending. Vasculitis may affect the large, medium, or small blood vessels. Small-vessel vas- culitis may be further classified as ANCA-associated or non-ANCA–associated vasculitis. ANCA–asso- ciated small-vessel vasculitis includes microscopic polyangiitis, Wegener’s granulomatosis, Churg- Strauss syndrome, and drug-induced vasculitis. Better definition criteria and advancement in the technologies make these diagnoses increasingly common. Features that may aid in defining the spe- cific type of vasculitic disorder include the type of organ involvement, presence and type of ANCA (myeloperoxidase–ANCA or proteinase 3–ANCA), presence of serum cryoglobulins, and the presence of evidence for granulomatous inflammation. Family physicians should be familiar with this group of vasculitic disorders to reach a prompt diagnosis and initiate treatment to prevent end-organ dam- age. Treatment usually includes corticosteroid and immunosuppressive therapy. (Am Fam Physician 2002;65:1615-20. Copyright© 2002 American Academy of Family Physicians.) asculitis is a process caused These antibodies can be detected with indi- by inflammation of blood rect immunofluorescence microscopy.
    [Show full text]
  • Immune-Pathophysiology and -Therapy of Childhood Purpura
    Egypt J Pediatr Allergy Immunol 2009;7(1):3-13. Review article Immune-pathophysiology and -therapy of childhood purpura Safinaz A Elhabashy Professor of Pediatrics, Ain Shams University, Cairo Childhood purpura - Overview vasculitic disorders present with palpable Purpura (from the Latin, purpura, meaning purpura2. Purpura may be secondary to "purple") is the appearance of red or purple thrombocytopenia, platelet dysfunction, discolorations on the skin that do not blanch on coagulation factor deficiency or vascular defect as applying pressure. They are caused by bleeding shown in table 1. underneath the skin. Purpura measure 0.3-1cm, A thorough history (Table 2) and a careful while petechiae measure less than 3mm and physical examination (Table 3) are critical first ecchymoses greater than 1cm1. The integrity of steps in the evaluation of children with purpura3. the vascular system depends on three interacting When the history and physical examination elements: platelets, plasma coagulation factors suggest the presence of a bleeding disorder, and blood vessels. All three elements are required laboratory screening studies may include a for proper hemostasis, but the pattern of bleeding complete blood count, peripheral blood smear, depends to some extent on the specific defect. In prothrombin time (PT) and activated partial general, platelet disorders manifest petechiae, thromboplastin time (aPTT). With few exceptions, mucosal bleeding (wet purpura) or, rarely, central these studies should identify most hemostatic nervous system bleeding;
    [Show full text]
  • Anti-Glomerular Basement Membrane (GBM) Disease (Goodpasture's Syndrome)
    Patient information – Goodpasture’s Syndrome Anti-Glomerular Basement Membrane (GBM) Disease (Goodpasture’s Syndrome) What is it? Goodpasture’s Syndrome is a type of vasculitis (inflammation of blood vessels), which affects the kidneys and the lungs. What causes it? The body normally produces antibodies to fight off infection and disease. In this case, your body makes an antibody that can attack and damages a membrane in your kidneys and lungs. What symptoms might I have? You may feel short of breath and cough up blood. The kidney damage may cause blood-stained or frothy urine or actual kidney failure. Is it serious? Without treatment, the condition can be life-threatening. In some cases, it may be too advanced for treatment to save the kidneys and dialysis will be necessary. However, powerful treatment is now very successful in saving lives and kidney function. Inpatient treatment As soon as diagnosis is made (on blood test or kidney biopsy), treatment will start with Prednisolone (steroid) and Cyclophosphamide (immunosuppressant). · Prednisolone 1mg/Kg of body weight (max 60mg) · IV Cyclophosphamide · Plasma exchange daily for 14 days or until antibody negative Discharge medication [Week One] Prednisolone Inpatient dose Lansoprazole 30mg daily Alendronate (non-dialysis) 70mg weekly Nystatin 1ml four times a day Septrin 480mg daily Anti-GBM Disease (Goodpasture’s Syndrome), March 2019 1 Anti-GBM Disease (Goodpasture’s Syndrome) Outpatient treatment The condition is dangerous, requiring powerful treatment that can have serious side effects. You will be seen often and monitored carefully. Your blood will be checked for its white cell count (WCC) to check how it would respond to infection.
    [Show full text]
  • DIFFERENTIAL DIAGNOSIS of Hypersensitivity Vasculitis
    HIGHLIGHTS FROM MEDICAL GRAND ROUNDS renal disease also is rare. However, certain types of kidney posure to an exogenous antigen such as a drug, serum, disease are associated with a higher incidence of hyper- toxin, or to an infection. Typically, the onset of vasculitis uricemia and gout, including chronic lead nephropathy, occurs 7 to 10 days after exposure to the antigen. The polycystic disease, amyloidosis, analgesic nephropathy, characteristic rash presents as palpable purpura, although and medullary cystic disease. Hypertension and its ulcers, nodules, bullae, or urticaria also may develop in therapy are associated with an increased incidence of some patients. hyperuricemia and gout. On biopsy, the lesions display polymorphonuclear The management of concurrent marked hyper- leukocytes and associated leukocytoclasis, but the in- uricemia and chronic renal disease is directed to preser- filtrates may be predominantly mononuclear. Im- vation of renal function, blood pressure control, and munofluorescent studies often show deposition of com- reduction of the serum uric acid. Uric acid homeostasis plement and immunoglobulins in vessel walls, and other can be achieved by maintaining urine flow (>2 L/d), techniques may show soluble immune complexes and restricting dietary purines and excessive alcohol, and, if evidence of complement activation; however, these needed, allopurinol in the lowest dose that can main- laboratory findings are neither universal nor necessary for tain a near-normal serum uric acid. Therapy should the diagnosis. start with 50 mg/d and increase in 50-mg increments The clinical course is usually self-limited. Varying until the level is under control. Generally, the dosage is degrees of fever, malaise, and weight loss may occur and 100 mg/d for every 30 cc/min of GFR.
    [Show full text]
  • Teledermatology and Common Dermatology Issues in the Hospitalized Patient
    Teledermatology and Common Dermatology Issues in the Hospitalized Patient Patricia Meyer, DNP, CRNP, FNP‐BC, AGACNP‐BC, NE‐BC The Rise of Teledermatology Improve Shortage of Ability for dermatology dermatology dermatologist to access providers see more patients • Obtaining a CC, HPI, ROS, Allergies, Med list , PMH, Social and Family Hx • A problem‐focused exam • Digital imaging • Uploading of‐ CC, HPI, ROS, Allergies, Med list , PMH, Social and Family Hx, Physical exam, and digital images via secure computer site • Onsite person to obtain BX if needed Teledermatology What is Involved After Info is Uploaded • Dermatologist will form differential diagnosis • Suggest a work up • Formulate and assessment and plan Teledermatology What is Involved • Medication list, prescription and over‐the‐counter drugs • History of past reactions to drugs or foods, topicals, soaps, detergents • Any recent illness ? Exposure to others with similar s/s • Any concurrent infections, metabolic disorders, or immunocompromise, or hx of History Needed autoimmune issues, hx of CA? • Any note in correlation with medication administration and rash onset? • How was medication administered? • Improvement if medication stopped and symptom reoccurrence if medication restarted? Worrisome • Mucous membrane erosions • Blisters Physical Exam • Nikolsky sign Features and • Confluent erythema symptoms • Angioedema and tongue swelling • Palpable purpura • Skin necrosis • Lymphadenopathy • High fever, dyspnea, or hypotension HJ is a 82 year old male, who was admitted from SNF, due to abd pain. HJ is being treated for diverticulitis with Cipro and Flagyl. Teledermatolgy is consulted due to a “rash.” Per the patient’s RN , “it is unclear if this is a new drug rash”. Upon further review with patient he states that he has had this rash for some time “it is very itchy and often keeps me up at night .” He denies any worsening or improving factors.
    [Show full text]
  • Hypersensitivity Reactions (Types I, II, III, IV)
    Hypersensitivity Reactions (Types I, II, III, IV) April 15, 2009 Inflammatory response - local, eliminates antigen without extensively damaging the host’s tissue. Hypersensitivity - immune & inflammatory responses that are harmful to the host (von Pirquet, 1906) - Type I Produce effector molecules Capable of ingesting foreign Particles Association with parasite infection Modified from Abbas, Lichtman & Pillai, Table 19-1 Type I hypersensitivity response IgE VH V L Cε1 CL Binds to mast cell Normal serum level = 0.0003 mg/ml Binds Fc region of IgE Link Intracellular signal trans. Initiation of degranulation Larche et al. Nat. Rev. Immunol 6:761-771, 2006 Abbas, Lichtman & Pillai,19-8 Factors in the development of allergic diseases • Geographical distribution • Environmental factors - climate, air pollution, socioeconomic status • Genetic risk factors • “Hygiene hypothesis” – Older siblings, day care – Exposure to certain foods, farm animals – Exposure to antibiotics during infancy • Cytokine milieu Adapted from Bach, JF. N Engl J Med 347:911, 2002. Upham & Holt. Curr Opin Allergy Clin Immunol 5:167, 2005 Also: Papadopoulos and Kalobatsou. Curr Op Allergy Clin Immunol 7:91-95, 2007 IgE-mediated diseases in humans • Systemic (anaphylactic shock) •Asthma – Classification by immunopathological phenotype can be used to determine management strategies • Hay fever (allergic rhinitis) • Allergic conjunctivitis • Skin reactions • Food allergies Diseases in Humans (I) • Systemic anaphylaxis - potentially fatal - due to food ingestion (eggs, shellfish,
    [Show full text]
  • Goodpasture Syndrome
    Goodpasture Syndrome National Kidney and Urologic Diseases Information Clearinghouse What is Goodpasture Goodpasture syndrome is sometimes called anti-GBM disease. However, anti-GBM syndrome? disease is only one cause of pulmonary- Goodpasture syndrome is a pulmonary- renal syndromes, including Goodpasture U.S. Department renal syndrome, which is a group of acute syndrome. of Health and illnesses involving the kidneys and lungs. Human Services Goodpasture syndrome includes all of the Goodpasture syndrome is fatal unless following conditions: quickly diagnosed and treated. NATIONAL INSTITUTES OF HEALTH • glomerulonephritis—inflammation of the glomeruli, which are tiny clusters What causes Goodpasture of looping blood vessels in the kidneys syndrome? that help filter wastes and extra water The causes of Goodpasture syndrome are from the blood not fully understood. People who smoke or • the presence of anti-glomerular base- use hair dyes appear to be at increased risk ment membrane (GBM) antibodies; for this condition. Exposure to hydrocar- the GBM is part of the glomeruli and bon fumes, metallic dust, and certain drugs, is composed of collagen and other such as cocaine, may also raise a person’s proteins risk. Genetics may also play a part, as a small number of cases have been reported • bleeding in the lungs in more than one family member. In Goodpasture syndrome, immune cells produce antibodies against a specific region What are the symptoms of of collagen. The antibodies attack the col- lagen in the lungs and kidneys. Goodpasture syndrome? The symptoms of Goodpasture syndrome Ernest Goodpasture first described the may initially include fatigue, nausea, vomit- syndrome during the influenza pandemic ing, and weakness.
    [Show full text]
  • Henoch-Schönlein Purpura in Children: Not Only Kidney but Also Lung
    Di Pietro et al. Pediatric Rheumatology (2019) 17:75 https://doi.org/10.1186/s12969-019-0381-y REVIEW Open Access Henoch-Schönlein Purpura in children: not only kidney but also lung Giada Maria Di Pietro1, Massimo Luca Castellazzi2, Antonio Mastrangelo3, Giovanni Montini3, Paola Marchisio1 and Claudia Tagliabue4* Abstract Background: Henoch-Schönlein Purpura (HSP) is the most common vasculitis of childhood and affects the small blood vessels. Pulmonary involvement is a rare complication of HSP and diffuse alveolar hemorrhage (DAH) is the most frequent clinical presentation. Little is known about the real incidence of lung involvement during HSP in the pediatric age and about its diagnosis, management and outcome. Methods: In order to discuss the main clinical findings and the diagnosis and management of lung involvement in children with HSP, we performed a review of the literature of the last 40 years. Results: We identified 23 pediatric cases of HSP with lung involvement. DAH was the most frequent clinical presentation of the disease. Although it can be identified by chest x-ray (CXR), bronchoalveolar lavage (BAL) is the gold standard for diagnosis. Pulse methylprednisolone is the first-line of therapy in children with DAH. An immunosuppressive regimen consisting of cyclophosphamide or azathioprine plus corticosteroids is required when respiratory failure occurs. Four of the twenty-three patients died, while 18 children had a resolution of the pulmonary involvement. Conclusions: DAH is a life-threatening complication of HSP. Prompt diagnosis and adequate treatment are essential in order to achieve the best outcome. Keywords: Henoch-Schönlein Purpura, IgA Vasculitis, Pulmonary involvement, Diffuse alveolar hemorrhage, Children Background significant risk of chronic renal impairment [3].
    [Show full text]
  • ALLERGIC RESPONSE to GLOMERULAR BASEMENT MEMBRANE in PATIENTS with GLOMERULONEPHRITIS by Momirimacanovic Renal Unit Department O
    Royal Postgraduate Medical School Library REFERENCE COPY NOT to be taken away ALLERGIC RESPONSE TO GLOMERULAR BASEMENT MEMBRANE IN PATIENTS WITH GLOMERULONEPHRITIS by MomiriMacanovic Renal Unit Department of Medicine Royal Postgraduate Medical School London W12 OHS. Ph.D. Thesis University of London 1973 ABSTRACT Glomeruli were isolated from normal human kidney cortex; glomeruli basement membrane prepared by ultrasonication of glomeruli, and soluble G.B.M. antigens finally prepared by proteolytic digestion of G.B.M. with collagenase. Specific anti-G.B.M. serum was produced in rabbits. The main antigenic components of soluble G.B.M. were immunochemically characterised as: one component of molecular weight over 200,000, the second component of molecular weight in the 20,000-100,000 and the third component containing small molecules of less than 10,000. Two high molecular components retained the antigenic properties, the last had been degraded to small non-antigenic fragments. Separate G.B.M. fractions are not uniform, but composed of multiple components of different molecular weight and size. In assessment of humoral allergic response to G.B.M. indirect immunofluorescence was found to correlate with the direct immunofluorescent method; double diffusion was found to be insufficient for the detection of circulating anti-G.B.M. antibodies; and among passive haemagglutination methods, glutaraldehyde method f chemical linkage of G.B.M. antigens to erythrocytes-was proved to be highly sensitive. Antibodies had been detected in rabbit anti-G.B.M. serum diluted more than 1:500,000. Circulating anti-G.B.M. antibodies were found in high titre in patients with linear deposits of IgG on the G.B.M.
    [Show full text]